Form 4 Filing: Robinson Chandler Sells $3.2M of $MNPR

INSIDER SALE

⚡ MATERIALITY: 8/10

corporate issuer

Monopar Therapeutics

Ticker: $MNPR

Transaction Value

$3.2M

Price/Share: $54.87

transaction date

2026-09-24

Shares: 58,112

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Robinson Chandler, holds the title of Chief Executive Officer at Monopar Therapeutics.

On 2026-09-24, the insider transacted 58,112 shares.The shares were transacted at a weighted average price of $54.87 per share, resulting in a total market-relevant value of $3.2M.

Executive Summary Summary

Robinson Chandler (Chief Executive Officer) sold $3.2M of $MNPR

Post-Transaction Position: 117,873 shares

SEC Accession No: 0001437749-26-031411 (CIK: 1727334)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$MNPR Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$MNPR News Coverage